MISSISSAUGA, Ontario , June 29, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc.  (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced the results of the matters voted upon at the Company's 2018 annual meeting (the "Meeting") of the shareholders of the Company (the "Shareholders")

-1Q 2018 Net Revenues Increased to $38.1 Million Versus $26.0 Million in 1Q 2017- MISSISSAUGA, Ontario , May 8, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (" Aralez " or the " Company ") today announced financial results for the first quarter ending March 31, 2018 .

-4Q 2017 Net Revenues Increased to $28.0 Million Versus $20.0 Million in the 4Q 2016- -Full-Year Net Revenues Increased to $105.9 Million Versus $54.3 Million in Full-Year 2016- -Provides 2018 Full-Year Financial Guidance- MISSISSAUGA, Ontario , March 13, 2018 /PRNewswire/ -- Aralez Pharmaceuticals

  -3Q 2017 Net Revenues of $24.3 Million ; Year-to-Date 2017 Net Revenues of $77.9 Million -   -Implements Fiscal Improvements designed to Deliver Profitability, Support Growth & Extend Cash Runway- -Provides Updated 2017 Full-Year Guidance and Preliminary 2018 Full-Year Outlook- MISSISSAUGA,